JPH0665043A - Skin external preparation - Google Patents

Skin external preparation

Info

Publication number
JPH0665043A
JPH0665043A JP4217862A JP21786292A JPH0665043A JP H0665043 A JPH0665043 A JP H0665043A JP 4217862 A JP4217862 A JP 4217862A JP 21786292 A JP21786292 A JP 21786292A JP H0665043 A JPH0665043 A JP H0665043A
Authority
JP
Japan
Prior art keywords
skin
external preparation
superoxide
dried
aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4217862A
Other languages
Japanese (ja)
Other versions
JP3101090B2 (en
Inventor
Mariko Muto
真理子 武藤
Tomeyoshi Suzuki
留佳 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP04217862A priority Critical patent/JP3101090B2/en
Publication of JPH0665043A publication Critical patent/JPH0665043A/en
Application granted granted Critical
Publication of JP3101090B2 publication Critical patent/JP3101090B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a skin external preparation. having stable and excellent effects on improvement of chapped skin, prevention of aging of skin, etc., by containing extract of a rosaceous plant and a superoxide dissmutase. CONSTITUTION:The objective skin external preparation contains one or two or more kinds of substances selected from extracts of rosaceous plant such as dried flower bud of Rosa rugosa var. plena Regel, dried seed of Prunus japonica Thunb. and dried fruit of Chaenomeles lagenaria Koidz. in an amount of 0.0001-10wt.% based on dried solid content and superoxide dissmutase which is a superoxide-removing enzyme distributed in living organisms such as animals, plants, microorganisms in an amount of 0.0001-5wt.% based on dried solid content, respectively. This preparation can be formulated as lotion, cream, cosmetic water, cleansing cream, pack, cleansing agent, foundation, etc., skin external preparation for dispersion type, granular or ointment-like medicine, quasi-drug and cosmetic. The preparation has an active oxygen removing action and extremely high preventing effects on production of lipoperoxide which results from production of active oxygen in the skin due to ultraviolet rays, inflammation, blackening, aging, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮膚外用剤に関し、さ
らに詳しくは、優れた活性酸素除去作用を有し、脂質の
過酸化防止効果、皮膚老化防止効果、肌荒れ改善効果等
を有する化粧品、医薬品等の皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin, more specifically, a cosmetic having an excellent active oxygen removing action, a lipid peroxidation preventing effect, a skin aging preventing effect, a skin roughening improving effect, and the like. The present invention relates to an external preparation for skin such as pharmaceuticals.

【0002】[0002]

【従来の技術】皮膚の老化には、皮膚中での活性酸素の
生成が大きく関わっていることが明らかにされつつあ
る。そこで近年では、皮膚の老化防止の目的で、活性酸
素生成防止剤や活性酸素除去剤、酸化防止剤などが皮膚
外用剤に応用されることが多くなってきた。
2. Description of the Related Art It is becoming clear that the generation of active oxygen in the skin is greatly involved in the aging of the skin. Therefore, in recent years, active oxygen production inhibitors, active oxygen scavengers, antioxidants, and the like have been increasingly applied to external skin preparations for the purpose of preventing skin aging.

【0003】また一方、肌荒れ改善や、皮膚老化防止に
対する薬効成分としては、アラントイン、アロエ抽出
物、人参抽出物、胎盤抽出物、牛血液除蛋白物、発酵代
謝物等が知られている。
On the other hand, as the medicinal components for improving skin roughness and preventing skin aging, allantoin, aloe extract, ginseng extract, placenta extract, bovine blood deproteinate, fermented metabolite and the like are known.

【0004】しかしながら、これらの薬効成分を配合し
た皮膚外用剤は、肌荒れ改善や皮膚老化防止に対して充
分な効果を発揮できず、より優れた細胞賦活作用を有す
る皮膚外用剤の開発が望まれていた。
However, the skin external preparations containing these medicinal components cannot exert a sufficient effect for improving rough skin and preventing skin aging, and development of a skin external preparation having a more excellent cell activating effect is desired. Was there.

【0005】一方、マイカイカ、モッカ及びイクリニン
等のバラ科植物の抽出物が、抗炎症作用及び美白効果を
有することが知られている(特開平3−127714
号)。
On the other hand, it is known that extracts of Rosaceae plants such as squid, mocca and iclinin have an anti-inflammatory effect and a whitening effect (JP-A-3-127714).
issue).

【0006】[0006]

【発明が解決しようとする課題】しかしながら、マイカ
イカ、モッカ及びイクリニンの抽出物(以下、植物抽出
物と称することがある)を単独で配合した場合の肌荒れ
改善作用や老化防止作用に対する効果は十分なものとは
いえず、また他の基剤等の影響により上記植物抽出物の
本来含有する効果が発揮され得ないのが実情であった。
さらに、より高い効果を得る目的で植物抽出物を高温度
で配合した場合の作用効果にも限界があり、逆に、植物
抽出物自体の有する特有の色やにおいの発生により配合
量や剤型等、製品面における制限も生じてくるといった
問題もあった。
However, when the extract of mica, mokka and iclinin (hereinafter sometimes referred to as plant extract) is blended alone, the effect of improving skin roughness and preventing aging is sufficient. It cannot be said that this is not the case, and the actual effect that the above plant extract originally contained cannot be exerted due to the influence of other bases and the like.
In addition, there is a limit to the action and effect when a plant extract is mixed at a high temperature for the purpose of obtaining a higher effect, and conversely, due to the generation of a unique color and odor of the plant extract itself, the amount and dosage form However, there was a problem that product restrictions would occur.

【0007】[0007]

【課題を解決するための手段】このような実情に鑑み、
本発明者等は、上記植物抽出物の有する皮膚作用効果を
十分に引き出すべく鋭意研究を行なった結果、植物抽出
物とスーパーオキサイドディスムターゼとを併用するこ
とにより、肌荒れ改善作用及び皮膚老化防止作用に対す
る効果が相乗的に発揮され、かつ皮膚外用剤として植物
抽出物が本来有する作用効果を安定的に得られることを
見出し、本発明を完成した。
[Means for Solving the Problems] In view of such a situation,
The present inventors, as a result of intensive research in order to sufficiently bring out the skin action effect of the plant extract, by using a plant extract and superoxide dismutase in combination, for rough skin improving action and skin aging preventing action. The present invention has been completed by finding that the effects are synergistically exerted and that the action and effect originally possessed by the plant extract as a skin external preparation can be stably obtained.

【0008】すなわち、本発明は、(A)マイカイカ、
モッカ及びイクリニンから選ばれる植物の抽出物の1種
又は2種以上、並びに(B)スーパーオキサイドディス
ムターゼを含有することを特徴とする皮膚外用剤を提供
するものである。
That is, the present invention relates to (A) mica
It is intended to provide an external preparation for skin, which comprises one or more kinds of plant extracts selected from mocca and icrinin, and (B) superoxide dismutase.

【0009】本発明の(A)成分の植物抽出物の調製法
は特に限定されないが、例えば種々の適当な溶媒を用い
て室温〜加温下で抽出される。抽出溶媒としては、例え
ば水;メチルアルコール、エチルアルコール等の低級一
価アルコール;グリセリン、プロピレングリコール、
1,3−ブチレングリコール等の液状多価アルコール;
酢酸エチル等の低級アルキルエステル;ベンゼン、ヘキ
サン等の炭化水素;ジエチルエーテル等のエーテル類等
の一種又は二種以上を用いることができる。特に水、エ
チルアルコール、グリセリン、1,3−ブチレングリコ
ールの一種又は二種以上の混合溶媒が好ましい。また抽
出条件としては、植物に対し容量比で1〜1000倍
量、特に5〜100倍量の溶媒を用い、4℃以上、特に
15〜30℃の温度で1時間以上、特に1〜3日間行う
のが好ましい。
The method for preparing the plant extract of the component (A) of the present invention is not particularly limited, but it is extracted, for example, using various suitable solvents at room temperature to under heating. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; glycerin, propylene glycol,
Liquid polyhydric alcohols such as 1,3-butylene glycol;
One or more lower alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; ethers such as diethyl ether can be used. In particular, water, ethyl alcohol, glycerin, and a mixed solvent of one or more kinds of 1,3-butylene glycol are preferable. As the extraction conditions, a solvent is used in a volume ratio of 1 to 1000 times, especially 5 to 100 times, and a temperature of 4 ° C or higher, particularly 15 to 30 ° C, for 1 hour or longer, particularly for 1 to 3 days. It is preferable to carry out.

【0010】以上のような条件で得られる植物抽出物
は、抽出された溶液のまま用いても良いが、更に必要に
より濃縮、ろ過等の処理をしたものを用いることができ
る。また、これらは単独でも、2種以上を組合せて使用
することもできる。
The plant extract obtained under the above conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to a treatment such as concentration and filtration. These may be used alone or in combination of two or more.

【0011】本発明の皮膚外用剤における植物抽出物の
配合量は、好ましくは乾燥固形分として0.0001〜
10重量%(以下単に「%」で示す)であり、好ましく
は0.01〜5%である。
The compounding amount of the plant extract in the external preparation for skin of the present invention is preferably 0.0001 to dry solid content.
It is 10% by weight (hereinafter, simply referred to as "%"), preferably 0.01 to 5%.

【0012】含有量が0.0001%未満であると効果
が充分発揮されず、10.0%を超えてもそれ以上の効
果の増大は見られない。
If the content is less than 0.0001%, the effect is not sufficiently exhibited, and if it exceeds 10.0%, no further increase in the effect is observed.

【0013】一方、本発明の他の必須成分である(B)
成分のスーパーオキサイドディスムターゼ(以下、「S
OD」という)は、動物、植物、微生物等の生体内に広
く分布するスーパーオキサイド消去酵素であり、その起
源や取得方法は特に限定されない。
On the other hand, the other essential component of the present invention (B)
Superoxide dismutase (hereinafter referred to as "S
"OD") is a superoxide scavenging enzyme widely distributed in living bodies such as animals, plants and microorganisms, and its origin and acquisition method are not particularly limited.

【0014】このSODの製造方法としては、ヒト、
牛、犬など動物組織から抽出したものでも、キャベツ、
キュウリ、レタスなど植物から抽出したものでも、微生
物が生産したものを抽出したものでもよく、また遺伝子
操作によって製造したものでもよい。更にSODを主成
分とするものであれば必ずしも精製しなくてもよい。
As a method for producing this SOD, humans,
Even if extracted from animal tissues such as cows and dogs, cabbage,
It may be one extracted from plants such as cucumber and lettuce, one extracted from a microorganism, or one produced by genetic engineering. Further, if SOD is the main component, it need not be purified.

【0015】これらSODの本発明皮膚外用剤中の配合
量は、一般には0.00001%〜5%、好ましくは
0.001〜3%である。SODの含有量が0.000
01%より少ない場合は、十分な効果が得られないこと
があり、また、5%を超えて配合してもそれ以上の効果
の増大は見られず、かえって製剤面で悪影響が生じる場
合がある。
The content of these SODs in the external preparation for skin of the present invention is generally 0.00001% to 5%, preferably 0.001 to 3%. SOD content is 0.000
If it is less than 01%, sufficient effect may not be obtained, and even if it exceeds 5%, further increase in effect may not be observed, and adverse effects may occur on the formulation side. .

【0016】さらに、本発明の皮膚外用剤には、本発明
の効果を損なわない範囲で、前記必須成分の他、通常の
皮膚外用剤に用いられる水性成分、粉体、界面活性剤、
油剤、保湿剤、アルコール類、pH調整剤、防腐剤、色
素、酸化防止剤、紫外線吸収剤、増粘剤、香料、美容成
分等を必要に応じて適宜配合することができる。
Further, the external preparation for skin of the present invention contains, in addition to the above-mentioned essential components, an aqueous component, a powder, a surfactant, which is used in ordinary external preparations for skin, within a range that does not impair the effects of the present invention.
Oil agents, moisturizers, alcohols, pH adjusters, preservatives, pigments, antioxidants, ultraviolet absorbers, thickeners, fragrances, cosmetic ingredients and the like can be appropriately added as necessary.

【0017】本発明の皮膚外用剤は、必須成分の(A)
及び(B)成分を配合し、常法に従って製造することが
できる。そして、乳液、クリーム、化粧水、美容液、ク
レンジング、パック、洗浄料、ファンデーション等や、
その他分散状、顆粒状、軟膏状等の医薬用、医薬部外用
又は化粧用の皮膚外用剤として適用することができる。
The external preparation for skin of the present invention comprises the essential component (A)
And component (B) may be blended to produce the composition according to a conventional method. And emulsion, cream, lotion, beauty essence, cleansing, pack, cleaning agent, foundation, etc.,
In addition, it can be applied as a skin external medicine for dispersion, granule, ointment or the like, for external use for quasi-drugs or for cosmetics.

【0018】[0018]

【実施例】次に、試験例および実施例を挙げ本発明を更
に詳しく説明するが、本発明はこれらになんら制約され
るものではない。
EXAMPLES Next, the present invention will be described in more detail with reference to test examples and examples, but the present invention is not limited thereto.

【0019】試験例1 スーパーオキサイド除去活性測定試験:乾燥したマイカ
イカ20重量部に50V/V%エチルアルコール80重
量部を加え、室温で時々撹拌しながら3日間抽出し、濾
過してマイカイカ抽出液を得た。これを試料として、下
記測定方法によりスーパーオキサイド除去活性を測定し
た。また、市販のSODおよびこれをマイカイカ抽出物
と組み合わせたものについてもあわせて活性を測定し
た。これらの結果を表1に示す。
Test Example 1 Superoxide removing activity measurement test: To 20 parts by weight of dried mica, 80 parts by weight of 50 V / V% ethyl alcohol was added, and the mixture was extracted for 3 days with occasional stirring at room temperature and filtered to obtain a mica extract. Obtained. Using this as a sample, the superoxide removing activity was measured by the following measuring method. In addition, the activity was also measured for commercially available SOD and a combination of this with a squid extract. The results are shown in Table 1.

【0020】(測定方法)0.05M炭酸ナトリウム緩
衝液(pH10.2)2.4mlに基質溶液〔3.0mMキサ
ンチン(0.05M炭酸ナトリウム緩衝液に溶解)〕
0.1ml、3.0mMEDTA0.1ml、0.15%(W
/V)ウシ血清アルブミン、0.75mMニトロブル−テ
トラゾリウム0.1ml及び各試料0.1mlを混合し、2
5℃で10分間放置した後、酵素溶液〔キサンチンオキ
シダーゼ溶液(精製水にて約0.04units/ml希
釈)〕0.1mlを加えて反応を開始する。25℃で20
分間インキュベートした後、6mM CaCl2 0.1m
lを加えて反応を停止する。次いで560nmにおける吸
光度(A)を測定する。
(Measurement method) Substrate solution in 2.4 ml of 0.05 M sodium carbonate buffer (pH 10.2) [3.0 mM xanthine (dissolved in 0.05 M sodium carbonate buffer)]
0.1 ml, 3.0 mM EDTA 0.1 ml, 0.15% (W
/ V) bovine serum albumin, 0.75 mM nitroblu-tetrazolium 0.1 ml and 0.1 ml of each sample are mixed, and 2
After standing at 5 ° C for 10 minutes, 0.1 ml of an enzyme solution [xanthine oxidase solution (diluted with purified water about 0.04 units / ml)] is added to start the reaction. 20 at 25 ° C
After incubating for 6 minutes, 6mM CaCl 2 0.1m
Stop the reaction by adding l. Then, the absorbance (A) at 560 nm is measured.

【0021】対照には検体のかわりに精製水を加えた試
料の吸光度(B)、また各試料のブランクには、6mM
CaCl2 0.1mlを加えて反応停止後に、キサンチ
ンオキシダーゼ0.1mlを添加した試料の吸光度(C)
を測定し、次式より、スーパーオキサイド除去率を算出
した。
The absorbance (B) of the sample to which purified water was added instead of the specimen was used as a control, and 6 mM was used as the blank of each sample.
Absorbance of a sample to which 0.1 ml of xanthine oxidase was added after stopping the reaction by adding 0.1 ml of CaCl 2 (C)
Was measured and the superoxide removal rate was calculated from the following formula.

【0022】[0022]

【数1】 [Equation 1]

【0023】A:試料の酵素反応による吸光度 B:対照の酵素反応による吸光度 C:試料の無酵素反応による吸光度A: Absorbance of sample by enzyme reaction B: Absorbance of control enzyme reaction C: Absorbance of sample without enzyme reaction

【0024】[0024]

【表1】 [Table 1]

【0025】*1:30V/V%エチルアルコールにて
加熱抽出後、ろ過し、減圧濃縮したものを冷所にて放置
して熟成させたもの。乾燥固形分約3%。 *2:シグマ社製;ウシ赤血球より得たもの、3.57
0units/mg
* 1: Heat-extracted with 30 V / V% ethyl alcohol, filtered, concentrated under reduced pressure, and then aged in a cool place for aging. About 3% dry solids. * 2: Sigma; obtained from bovine red blood cells, 3.57
0 units / mg

【0026】表1の結果より明らかな如く、マイカイカ
抽出物は単独でもSOD様作用を有していたが、SOD
と併用することにより、相乗的な作用を発揮し、活性酸
素除去に極めて有効であることが示された。
As is clear from the results shown in Table 1, the squid extract alone had an SOD-like action, but SOD
It was shown that when used in combination with, it exerts a synergistic effect and is extremely effective in removing active oxygen.

【0027】このことは、マイカイカ抽出物とSODを
併用した本発明の皮膚外用剤が、紫外線による皮膚中で
の活性酸素生成に起因する過酸化脂質の生成、炎症、黒
化、老化に対し、極めて高い予防効果を有することを示
すものである。
This means that the external preparation for skin of the present invention in which the squid extract and SOD are used in combination is effective against the production of lipid peroxide, inflammation, blackening and aging due to the production of active oxygen in the skin by ultraviolet rays. This shows that it has an extremely high preventive effect.

【0028】実施例1 乳液:表2に示す組成及び下記製法で乳液を調製し、そ
の美肌効果及び皮膚老化防止効果を調べた。この結果を
表5に示す。
Example 1 Emulsion: An emulsion was prepared according to the composition shown in Table 2 and the following production method, and its skin beautifying effect and skin aging preventing effect were examined. The results are shown in Table 5.

【0029】[0029]

【表2】 [Table 2]

【0030】(製法) A.成分(6)、(7)、(9)及び(13)を加熱混
合し、70℃に保つ。 B.成分(1)〜(5)及び(10)を加熱混合し、7
0℃に保つ。 C.BをAに加えて混合し、成分(12)を加えて均一
に乳化し、30℃まで冷却して、成分(8)及び(1
1)を加え、均一に混合して乳液を得る。
(Production Method) A. Ingredients (6), (7), (9) and (13) are heat mixed and maintained at 70 ° C. B. Heat-mix components (1) to (5) and (10),
Keep at 0 ° C. C. B is added to A and mixed, component (12) is added and the mixture is uniformly emulsified, cooled to 30 ° C., and components (8) and (1
1) is added and mixed uniformly to obtain an emulsion.

【0031】(試験方法)28〜58才の女性15名を
パネルとし、毎日、朝と夜の2回、12週間にわたって
洗顔後に被験乳液の適量を顔面に塗布した。塗布による
美肌及び皮膚老化防止効果を下の基準によって評価し
た。
(Test Method) 15 women aged 28 to 58 were used as a panel, and an appropriate amount of the test emulsion was applied to the face after washing the face twice daily in the morning and at night for 12 weeks. The beautiful skin and anti-aging effect of the application were evaluated according to the following criteria.

【0032】[0032]

【表3】 美肌効果: 〔評 価〕 〔内 容〕 有 効 肌のくすみが目立たなくなった。 やや有効 肌のくすみがあまり目立たなくなった。 無 効 使用前と変化なし。[Table 3] Skin beautifying effect: [Evaluation] [Contents] Effectiveness Dullness of the skin became inconspicuous. Somewhat effective The dullness of the skin became less noticeable. Ineffective No change from before use.

【0033】[0033]

【表4】 皮膚老化防止効果: 〔評 価〕 〔内 容〕 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。 (結果)[Table 4] Anti-aging effect on skin: [Evaluation] [Contents] Effectiveness The scalp and gloss of the skin were improved. Slightly effective Skin tone and gloss were slightly improved. Ineffective No change from before use. (result)

【0034】[0034]

【表5】 [Table 5]

【0035】実施例2 クリーム:表6に示す組成及び下記製法でクリームを調
製し、その美肌効果および皮膚老化防止効果を調べた。
この結果を表7に示す。
Example 2 Cream: A cream was prepared by the composition shown in Table 6 and the following production method, and its skin beautifying effect and skin aging preventing effect were examined.
The results are shown in Table 7.

【0036】[0036]

【表6】 [Table 6]

【0037】*3:50V/V%エチルアルコールにて
還流抽出後、ろ過し、減圧濃縮したものを冷所に放置し
たもの。乾燥固形分約2%。 *4:牛胎盤10kgを細切し、2倍量の5%V/Vエチ
ルアルコール水溶液を加え、37℃で6時間抽出した
後、ゲル濾過、透析などにより精製したもの。(吸量約
2kg)タンパク量 約1.0〜1.5% *5:キャベツ1kgを細切し、同量の精製水を加え、ホ
モジナイズする。濾過した後に硫安分画を行ない、透析
処理を行ったもの。(収量約10g)タンパク量 約
2.0〜4.0%
* 3: Reflux extraction with 50 V / V% ethyl alcohol, filtration, concentration under reduced pressure, and standing in a cool place. About 2% dry solids. * 4: 10 kg of bovine placenta, finely chopped, added with double volume of 5% V / V ethyl alcohol aqueous solution, extracted at 37 ° C for 6 hours, and then purified by gel filtration, dialysis and the like. (Absorption capacity of about 2 kg) Protein content of about 1.0 to 1.5% * 5: 1 kg of cabbage is cut into small pieces, and the same amount of purified water is added to homogenize. Ammonium sulfate fractionation after filtration and dialysis treatment. (Yield about 10g) Protein amount about 2.0-4.0%

【0038】(製法) A.成分(1)〜(7)、(11)および(12)を混
合し、加熱して70℃に保つ。 B.成分(8)および(13)を混合し、加熱して70
℃に保つ。 C.AにBを加え、混合した後、冷却して(9)(1
0)を加えて、均一に混合して、クリームを得た。 (試験方法)実施例1と同じ (評価基準)実施例1と同じ (結果)
(Production Method) A. Components (1)-(7), (11) and (12) are mixed and heated to maintain at 70 ° C. B. Mix components (8) and (13) and heat to 70
Keep at ℃. C. After adding B to A, mixing and cooling (9) (1
0) was added and mixed uniformly to obtain a cream. (Test method) Same as Example 1 (Evaluation criteria) Same as Example 1 (Result)

【0039】[0039]

【表7】 [Table 7]

【0040】表7の結果より明らかな如く、本発明品2
及び3のクリームは肌の「つや」や「はり」の喪失、
「くすみ」等の皮膚の老化現象の防止、改善に有効であ
った。
As is clear from the results of Table 7, the product 2 of the present invention
Creams # 3 and # 3 lose the skin's “shine” and “swelling”,
It was effective in preventing and improving skin aging phenomena such as "dullness".

【0041】実施例3 化粧水:Example 3 Lotion:

【表8】 (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレンソルビタン モノラウリン酸エステル(20E.O.) 1.2 (4)エチルアルコール 8.0 (5)モッカ抽出物 1.0 (6)SOD*6 0.5 (7)防腐剤 適量 (8)香料 適量 (9)精製水 残量 *6:シグマ社製;人赤血球より得たもの、5.230
units/mg
[Table 8] (Prescription) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene sorbitan monolaurate (20EO) 1.2 (4) ) Ethyl alcohol 8.0 (5) Mocca extract 1.0 (6) SOD * 6 0.5 (7) Preservative proper amount (8) Perfume proper amount (9) Purified water Remainder * 6: Sigma; human Obtained from red blood cells, 5.230
units / mg

【0042】(製法) A.成分(3)、(4)、(7)及び(8)を混合溶解
する。 B.成分(1)、(2)、(5)、(6)及び(9)を
混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
(Production Method) A. Components (3), (4), (7) and (8) are mixed and dissolved. B. Components (1), (2), (5), (6) and (9) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0043】実施例4 パック:Example 4 Pack:

【表9】 (処方) (%) (1)ポリビニルアルコール 20.0 (2)エチルアルコール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)モッカ抽出物 0.05 (6)SOD含有プラセンタエキス*7 0.01 (7)防腐剤 0.2 (8)香料 0.1 (9)精製水 残量 *7:実施例2のものを凍結乾燥したもの[Table 9] (Prescription) (%) (1) Polyvinyl alcohol 20.0 (2) Ethyl alcohol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Mokka extract 0.05 ( 6) Placenta extract containing SOD * 7 0.01 (7) Preservative 0.2 (8) Perfume 0.1 (9) Purified water Remainder * 7: Freeze-dried product of Example 2

【0044】(製法) A.成分(1)、(3)〜(5)及び(9)を混合し、
70℃に加熱し、撹拌する。 B.成分(2)、(7)及び(8)を混合する。 C.BをAに加え、混合した後、冷却して(6)を均一
に分散してパックを得た。
(Production Method) A. Mixing components (1), (3)-(5) and (9),
Heat to 70 ° C. and stir. B. Mix components (2), (7) and (8). C. B was added to A, mixed, and then cooled to uniformly disperse (6) to obtain a pack.

【0045】実施例5 洗浄料:Example 5 Cleaning Charge:

【表10】 (処方) (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 0.1 (8)防腐剤 0.2 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)イクリニン抽出物*8 0.5 (12)SOD*9 0.05 (13)精製水 残量 *8:50V/V%エチルアルコールを加え、時々振と
うしながら室温で3日間抽出後、ろ過し、減圧濃縮した
もの。乾燥固形分約6%。 *9:シグマ社製;ホースラデッシュより得たもの、
2.150units/mg
(Table 10) (Prescription) (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) Oleyl alcohol 1.5 (6) Purified lanolin 1.0 (7) Perfume 0.1 (8) Preservative 0.2 (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Iclinin extract * 8 0.5 (12) SOD * 9 0.05 (13) Purified water Residual amount * 8: 50 V / V% ethyl alcohol was added, and the mixture was extracted at room temperature for 3 days with occasional shaking, filtered, and concentrated under reduced pressure. About 6% dry solids. * 9: manufactured by Sigma; obtained from Horseradish,
2.150 units / mg

【0046】(製法) A.成分(9)、(10)及び(13)を混合し、70
℃に加熱する。 B.成分(1)〜(6)及び(8)を混合し、70℃に
加熱する。 C.上記Bを先のAに加え、しばらく70℃に保ち、け
ん化反応が終了後、50℃まで冷却し、成分(7)、
(11)及び(12)を加え、冷却して洗浄料を得た。
(Production Method) A. Mixing components (9), (10) and (13), 70
Heat to ℃. B. The components (1) to (6) and (8) are mixed and heated to 70 ° C. C. The above B was added to the above A, kept at 70 ° C. for a while, cooled to 50 ° C. after completion of the saponification reaction, and the component (7),
(11) and (12) were added and cooled to obtain a cleaning agent.

【0047】実施例6 ゲル軟膏:Example 6 Gel ointment:

【表11】 (処方) (%) (1)カルボキシビニルポリマー 1.0 (2)トリエタノールアミン 1.0 (3)1,3−ブチレングリコール 10.0 (4)イクリニン抽出物 0.01 (5)SOD 0.02 (6)精製水 残量Table 11 (Prescription) (%) (1) Carboxyvinyl polymer 1.0 (2) Triethanolamine 1.0 (3) 1,3-Butylene glycol 10.0 (4) Iclinin extract 0.01 ( 5) SOD 0.02 (6) Purified water Remaining amount

【0048】(製法) A.成分(1)及び(3)〜(6)を混合溶解する。 B.Aに成分(2)を加え、混合して均一にし、ゲル軟
膏を得た。
(Production Method) A. Components (1) and (3) to (6) are mixed and dissolved. B. Ingredient (2) was added to A, mixed and homogenized to obtain a gel ointment.

【0049】[0049]

【発明の効果】本発明の皮膚外用剤は、優れた活性酸素
除去作用を有するので、肌荒れ改善や、皮膚老化防止等
に安定で且つ優れた効果を有する。従って、本発明の皮
膚外用剤は、紫外線による皮膚中での活性酸素生成に起
因する過酸化脂質の生成、炎症、黒化、老化等に対し、
極めて高い予防効果を有するもので、美容や医療におい
て極めて有用なものである。
EFFECT OF THE INVENTION Since the external preparation for skin of the present invention has an excellent action of removing active oxygen, it has a stable and excellent effect for improving rough skin and preventing skin aging. Therefore, the external preparation for skin of the present invention, for the production of lipid peroxide due to the generation of active oxygen in the skin by ultraviolet rays, inflammation, blackening, aging, etc.,
It has an extremely high preventive effect and is extremely useful in beauty and medicine.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 (A)マイカイカ、モッカ及びイクリニ
ンから選ばれる植物の抽出物の1種又は2種以上、並び
に(B)スーパーオキサイドディスムターゼを含有する
ことを特徴とする皮膚外用剤。
1. An external preparation for skin comprising (A) one or more kinds of plant extracts selected from mica, mocca and iclinin, and (B) superoxide dismutase.
JP04217862A 1992-08-17 1992-08-17 External preparation for skin Expired - Lifetime JP3101090B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04217862A JP3101090B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04217862A JP3101090B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH0665043A true JPH0665043A (en) 1994-03-08
JP3101090B2 JP3101090B2 (en) 2000-10-23

Family

ID=16710935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04217862A Expired - Lifetime JP3101090B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3101090B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10279461A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JPH10279458A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
EP1104672A1 (en) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Cosmetic and/or pharmaceutical compositions
KR20040038243A (en) * 2002-10-31 2004-05-08 (주)마이코스메틱 Anti-oxidation or anti-aging skin cosmetic composition for containing the extracts of Rosa davurica Pall
JP2007119432A (en) * 2005-10-31 2007-05-17 Ichimaru Pharcos Co Ltd Activator of peroxisome proliferator-activated receptor (ppar)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10279461A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JPH10279458A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
EP1104672A1 (en) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Cosmetic and/or pharmaceutical compositions
KR20040038243A (en) * 2002-10-31 2004-05-08 (주)마이코스메틱 Anti-oxidation or anti-aging skin cosmetic composition for containing the extracts of Rosa davurica Pall
JP2007119432A (en) * 2005-10-31 2007-05-17 Ichimaru Pharcos Co Ltd Activator of peroxisome proliferator-activated receptor (ppar)

Also Published As

Publication number Publication date
JP3101090B2 (en) 2000-10-23

Similar Documents

Publication Publication Date Title
CN108904302A (en) A kind of fullerene topical composition
JPS60202806A (en) Whitening cosmetic
US20070254052A1 (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and their use
JPS6248611A (en) External preparation for skin
JPH0899820A (en) Skin external agent
JPH07277939A (en) Skin external preparation
JP3513872B2 (en) External preparation for skin
JP2004323406A (en) Humectant, method for using plant extract and external preparation
JPH0665044A (en) Skin external preparation
JP2002212087A (en) Skin care preparation
JPH03193712A (en) Cosmetic
JP2000327550A (en) Skin preparation for external use
JPH0532556A (en) Skin agent for external use
JPH04338313A (en) Cosmetic
JP3881411B2 (en) Composition suitable for external use
CN117045523A (en) High-content azelaic acid composition and preparation method thereof
JPH1029927A (en) Antiaging agent
JP3101090B2 (en) External preparation for skin
JPH1029924A (en) Antiaging agent
JP3319870B2 (en) Skin external composition and bath agent
JP3105664B2 (en) External preparation for skin
JP2004107269A (en) Carbonylation inhibiting agent for protein, skin care preparation for external use, and method
KR20030039726A (en) A cosmetic composition containing an extract of petasites japonicus
JP3747192B2 (en) Topical skin preparation
EP0503763A1 (en) Cosmetic material

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110818

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110818

Year of fee payment: 11

EXPY Cancellation because of completion of term